Previous studies demonstrated that the PPAR signaling pathway was involved in glucose homeostasis and lipid metabolism, and might be a target for the development of novel efficient treatments for several metabolic disorders, including obesity and type 2 diabetes [17]. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.